Literature DB >> 19926159

Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus.

Beata Telejko1, Mariusz Kuzmicki, Natalia Wawrusiewicz-Kurylonek, Jacek Szamatowicz, Agnieszka Nikolajuk, Anna Zonenberg, Dorota Zwierz-Gugala, Wojciech Jelski, Piotr Laudański, Jan Wilczynski, Adam Kretowski, Maria Gorska.   

Abstract

AIMS AND METHODS: Apelin is a novel adipokine identified as an endogenous ligand of the G protein-coupled receptor APJ. In this study we compared plasma apelin concentrations in 101 patients with gestational diabetes (GDM) and 101 women with normal glucose tolerance (NGT) between 24 and 32 weeks of gestation (Group 1), as well as in 20 women with GDM and 16 subjects with NGT at term (Group 2). Apelin and APJ mRNA expression in subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and placental tissue were also measured in Group 2, using quantitative real-time PCR.
RESULTS: There were no significant differences in plasma apelin levels between the women with GDM and NGT (Group 1: 1555.6 [1281.2-1804.2]pg/ml vs 1656.5 [1430.2-1852.1]pg/ml, Group 2: 1607.9 [1453.4-1768.7]pg/ml vs 1493.8 [1316.8-1956.7]pg/ml) nor in apelin and APJ mRNA expression in SAT, VAT and placental tissue. Apelin mRNA expression was approximately 10 fold higher in placental than in adipose tissue (p<0.0001). Apelin and APJ mRNA expression correlated significantly in SAT (R=0.45, p=0.03), VAT (R=0.69, p=0.003) and placental tissue (R=0.37, p=0.03).
CONCLUSIONS: No associations between circulating apelin or apelin/APJ mRNA expression and GDM or the indices of insulin resistance were noted in our study. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926159     DOI: 10.1016/j.diabres.2009.10.018

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  22 in total

Review 1.  Apelin, diabetes, and obesity.

Authors:  Isabelle Castan-Laurell; Cédric Dray; Camille Attané; Thibaut Duparc; Claude Knauf; Philippe Valet
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

2.  Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus.

Authors:  Mehmet Aslan; Onder Celik; Nilufer Celik; Ilgin Turkcuoglu; Ercan Yilmaz; Abdullah Karaer; Yavuz Simsek; Ebru Celik; Suleyman Aydin
Journal:  Endocrine       Date:  2011-12-28       Impact factor: 3.633

3.  Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity.

Authors:  Sarah-Maude Caron-Cantin; Julie Martin; Marjorie Bastien; Mercedes Nancy Munkonda; Huiling Lu; Katherine Cianflone; Fady Moustarah; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Jean Bussières; Paul Poirier
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

4.  Inflammation, a link between obesity and cardiovascular disease.

Authors:  Zhaoxia Wang; Tomohiro Nakayama
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

5.  Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells.

Authors:  Ratana Lim; Gillian Barker; Clyde Riley; Martha Lappas
Journal:  Reprod Sci       Date:  2013-01-11       Impact factor: 3.060

6.  Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls.

Authors:  M Boyadzhieva; I Atanasova; S Zacharieva; S Kedikova
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

7.  Characterization of visceral and subcutaneous adipose tissue transcriptome in pregnant women with and without spontaneous labor at term: implication of alternative splicing in the metabolic adaptations of adipose tissue to parturition.

Authors:  Shali Mazaki-Tovi; Adi L Tarca; Edi Vaisbuch; Juan Pedro Kusanovic; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Zhong Dong; Sonia S Hassan; Roberto Romero
Journal:  J Perinat Med       Date:  2016-10-01       Impact factor: 1.901

8.  Increased Maternal and Cord Blood Betatrophin in Gestational Diabetes.

Authors:  Natalia Wawrusiewicz-Kurylonek; Beata Telejko; Mariusz Kuzmicki; Angelika Sobota; Danuta Lipinska; Justyna Pliszka; Beata Raczkowska; Pawel Kuc; Remigiusz Urban; Jacek Szamatowicz; Adam Kretowski; Piotr Laudanski; Maria Gorska
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

9.  The Potential Role of Chemerin, Lipocalin 2, and Apelin in the Diagnosis and Pathophysiology of Gestational Diabetes Mellitus.

Authors:  Radzisław Mierzyński; Elżbieta Poniedziałek-Czajkowska; Dominik Dłuski; Maciej Kamiński; Agnieszka Mierzyńska; Bożena Leszczyńska-Gorzelak
Journal:  J Diabetes Res       Date:  2021-06-09       Impact factor: 4.011

10.  Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.

Authors:  Maria Gisella Cavallo; Federica Sentinelli; Ilaria Barchetta; Carmine Costantino; Michela Incani; Laura Perra; Danila Capoccia; Stefano Romeo; Efisio Cossu; Frida Leonetti; Luciano Agati; Marco G Baroni
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.